Matthew W Reynolds

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. ncbi Persistence and adherence to disease modifying drugs among patients with multiple sclerosis
    Matthew W Reynolds
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 26:663-74. 2010
  2. ncbi Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients
    Michael E Stokes
    United BioSource Corporation, Montreal, QC, Canada
    BMC Health Serv Res 11:135. 2011
  3. ncbi Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis
    Matthew W Reynolds
    United BioSource Corporation, Medford, MA 02155, USA
    Curr Med Res Opin 24:497-505. 2008
  4. ncbi Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature
    Matthew W Reynolds
    Epidemiology and Database Services, United BioSource Corporation, Medford, MA, USA
    Patient Saf Surg 2:5. 2008
  5. ncbi Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs
    Matthew W Reynolds
    Center for Epidemiology and Database Analytics, United BioSource Corporation, 430 Bedford Street, Lexington, MA 02420, USA
    J Med Econ 13:90-8. 2010
  6. ncbi A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data
    Gary Schneider
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:240-7. 2012
  7. ncbi A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data
    Gary Schneider
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:248-55. 2012
  8. ncbi A systematic review of validated methods for identifying acute respiratory failure using administrative and claims data
    Natalie Jones
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:261-4. 2012
  9. ncbi A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data
    Natalie Jones
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:256-60. 2012
  10. ncbi Bovine thrombin safety reporting: an example of study design and publication bias
    Sheila Crean
    United BioSource Corporation, Medford, Massachusetts 02155, USA
    J Surg Res 158:77-86. 2010

Collaborators

Detail Information

Publications20

  1. ncbi Persistence and adherence to disease modifying drugs among patients with multiple sclerosis
    Matthew W Reynolds
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 26:663-74. 2010
    ....
  2. ncbi Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients
    Michael E Stokes
    United BioSource Corporation, Montreal, QC, Canada
    BMC Health Serv Res 11:135. 2011
    ..This study examines the incidence and costs of bleeding-related complications and/or blood product transfusions occurring as a consequence of surgery in various inpatient surgical cohorts...
  3. ncbi Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis
    Matthew W Reynolds
    United BioSource Corporation, Medford, MA 02155, USA
    Curr Med Res Opin 24:497-505. 2008
    ....
  4. ncbi Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature
    Matthew W Reynolds
    Epidemiology and Database Services, United BioSource Corporation, Medford, MA, USA
    Patient Saf Surg 2:5. 2008
    ..Recent studies have failed to establish significant differences in the rates of bleeding events between those treated with bovine thrombin and those treated with either human or recombinant thrombin...
  5. ncbi Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs
    Matthew W Reynolds
    Center for Epidemiology and Database Analytics, United BioSource Corporation, 430 Bedford Street, Lexington, MA 02420, USA
    J Med Econ 13:90-8. 2010
    ..Secondary objectives included an assessment of the time to switch or discontinuation from index DMD treatment...
  6. ncbi A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data
    Gary Schneider
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:240-7. 2012
    ..This article summarizes the process and findings of the algorithm review of anaphylaxis...
  7. ncbi A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data
    Gary Schneider
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:248-55. 2012
    ..This article summarizes the process and findings of the algorithm review of hypersensitivity reactions...
  8. ncbi A systematic review of validated methods for identifying acute respiratory failure using administrative and claims data
    Natalie Jones
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:261-4. 2012
    ..This paper summarizes the process and findings of the algorithm review of acute respiratory failure (ARF)...
  9. ncbi A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data
    Natalie Jones
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:256-60. 2012
    ..This paper summarizes the process and findings of the algorithm review of pulmonary fibrosis and interstitial lung disease...
  10. ncbi Bovine thrombin safety reporting: an example of study design and publication bias
    Sheila Crean
    United BioSource Corporation, Medford, Massachusetts 02155, USA
    J Surg Res 158:77-86. 2010
    ..We sought to compare adverse event rates of early observational studies with those of later interventional trials...
  11. ncbi A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data
    Gary Schneider
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 21:236-9. 2012
    ..This paper summarizes the process and findings of the algorithm review of erythema multiforme and related conditions...
  12. ncbi Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System
    John A Clark
    United BioSource Corporation, Lexington, MA 02420, USA
    Pharmacoepidemiol Drug Saf 19:107-14. 2010
    ..To review topical bovine thrombin spontaneous adverse event (AE) reports that were forwarded to the US Food and Drug Administration's (FDA) Adverse Event Reporting System (AERS) between January 1986 and December 2006...
  13. ncbi Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation
    Catherine J Mercaldi
    United BioSource Corp, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Stroke 42:112-8. 2011
    ..This report describes the extent of warfarin use, its effectiveness, and its impact on medical costs among Medicare patients with nonvalvular atrial fibrillation...
  14. ncbi Costs associated with febrile neutropenia in the US
    Shannon L Michels
    United BioSource Corporation, Lexington, MA, USA
    Pharmacoeconomics 30:809-23. 2012
    ..This study was designed to estimate US healthcare utilization and costs in those experiencing FN by location of care, tumour type and mortality...
  15. ncbi Quality of life and economic costs associated with postthrombotic syndrome
    Sumesh Kachroo
    United BioSourceCorporation, 430 Bedford Street, Lexington, MA 02420, USA
    Am J Health Syst Pharm 69:567-72. 2012
    ..Published evidence on quality-of-life (QOL) outcomes and health care costs in patients with postthrombotic syndrome (PTS), a common and difficult-to-diagnose complication of venous thromboembolism (VTE), is reviewed...
  16. ncbi Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review
    Shannon L Michels
    United BioSource Corporation, Lexington, MA 02420, USA
    Curr Med Res Opin 28:89-99. 2012
    ..Although the literature on gastrointestinal (GI) safety of NSAID therapy is extensive, the risk profiles of OTC and prescription dosing are seldom separated, and few studies provide risks specific to OTC ibuprofen...
  17. ncbi Exogenous bovine thrombin as a biomarker of exposure and outcome
    Sheila M Crean
    Epidemiologist, Health Care Analytics Group, United BioSource Corporation, 101 Station Landing, Medford, MA, USA
    Expert Rev Mol Diagn 8:651-61. 2008
    ..Conventional tests for hypocoagulation were common (86%); however, only 9% of papers confirmed this inhibition as an isolated antibody. In addition, only 9% of papers cited a specific biomarker for thrombosis...
  18. ncbi Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims database
    Catherine J Mercaldi
    United BioSource Corporation, Bethesda, Maryland, USA
    JPEN J Parenter Enteral Nutr 36:330-6. 2012
    ..This study was undertaken to assess the feasibility of comparing custom-compounded and MCB PN in a large hospital claims database...
  19. ncbi Topical bovine thrombin and adverse events: a review of the literature
    John Clark
    United BioSource Corporation, Medford, MA 02155, USA
    Curr Med Res Opin 24:2071-87. 2008
    ..To review published evidence suggesting a link between topical bovine thrombin (TBT) and important adverse events (AEs)...
  20. ncbi Reliable evidence of safety and efficacy of elderly patients in randomized clinical trials still needed
    Sheila M Crean
    J Clin Oncol 25:4027-8; author reply 4028. 2007